Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Cumberland Pharmaceuticals (CPIX) over the last 5 years, with Sep 2025 value amounting to $9,651.

  • Cumberland Pharmaceuticals' Gains from Investment Securities rose 101.95% to $9,651 in Q3 2025 from the same period last year, while for Sep 2025 it was -$431,503, marking a year-over-year increase of 63.19%. This contributed to the annual value of -$1.5 million for FY2024, which is 16.51% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Gains from Investment Securities of $9,651 as of Q3 2025, which was down 75.00% from $38,602 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Gains from Investment Securities peaked at $5.6 million during Q4 2022, and registered a low of -$983,574 during Q3 2022.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Gains from Investment Securities value was -$230,430 (recorded in 2024), while the average stood at -$238,310.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Gains from Investment Securities spiked by 792.41% in 2022, and later tumbled by 172.24% in 2023.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Gains from Investment Securities stood at $632,319 in 2021, then soared by 792.41% to $5.6 million in 2022, then plummeted by 104.18% to -$236,128 in 2023, then slumped by 122.22% to -$524,732 in 2024, then spiked by 101.95% to $9,651 in 2025.
  • Its last three reported values are $9,651 in Q3 2025, $38,602 for Q2 2025, and $44,976 during Q1 2025.